Last updated on May 2019

A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis


Brief description of study

The reason for this study is to see if the study drug LY3375880 is safe and effective in adults with moderate-to-severe atopic dermatitis (AD).

Clinical Study Identifier: NCT03831191

Find a site near you

Start Over

Meiwa Hospital

Nishinomiya, Japan
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.